{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T22:20:02Z","timestamp":1776810002409,"version":"3.51.2"},"reference-count":23,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Nephrology"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The 2021 KDIGO clinical practice guideline for the management of blood pressure (BP) in chronic kidney disease (CKD) provided significant practice\u2010changing recommendations for the care of both adult and paediatric CKD patients not receiving dialysis. The purpose of this review is to contextualise these recommendations and evaluate their applicability to the Australian and New Zealand context. Key updates presented in this guideline relate to measurement techniques, with a strong recommendation for standardised office BP measurement, as opposed to routine office BP measurement. Standardised measurement is more nuanced, compared to routine measurement, in terms of patient preparation, technique, timing, and duration of measurement, which may produce more accurate measurements but may require restructuring of clinical appointments and retraining of staff. The target systolic BP level for non\u2010dialysis, non\u2010transplant adult CKD patients suggested is &lt;120\u2009mmHg. The lifestyle and pharmacological interventions for lowering BP include regular exercise, a low\u2010sodium diet, and renin\u2010angiotensin\u2010system (RAS) inhibitors in patients with comorbid diabetes or albuminuria. This commentary identifies several patient subgroups requiring further investigation and clinical guidance, including diabetic CKD, dialysis and transplant recipients with CKD, and paediatric CKD, and highlights the importance of further exploring the effect of SGLT2 inhibitors on high BP in CKD patients.<\/jats:p>","DOI":"10.1111\/nep.14414","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T01:25:47Z","timestamp":1735262747000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Commentary on the 2021 update of the <scp>KDIGO<\/scp> clinical practice guideline for management of blood pressure in chronic kidney disease"],"prefix":"10.1111","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4436-4319","authenticated-orcid":false,"given":"Emily J.","family":"See","sequence":"first","affiliation":[{"name":"Department of Nephrology Royal Melbourne Hospital  Melbourne Victoria Australia"},{"name":"Department of Nephrology Royal Children's Hospital  Melbourne Victoria Australia"},{"name":"Department of Intensive Care Royal Melbourne Hospital  Melbourne Victoria Australia"},{"name":"Department of Critical Care University of Melbourne  Melbourne Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Cullen","sequence":"additional","affiliation":[{"name":"Forward Thinking Design  Sydney New South Wales Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the Caring for Australians and New Zealanders with Kidney Impairment (CARI) Guideline Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,12,26]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02240311"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014070714"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2017020148"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1511939"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.11.003"},{"issue":"1","key":"e_1_2_7_7_1","first-page":"1","article-title":"Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Levin A","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.090449"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013030285"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2020.05.006"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.06.019"},{"issue":"6","key":"e_1_2_7_12_1","first-page":"E13","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"71","author":"Whelton PK","year":"2018","journal-title":"Hypertension"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.009326"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011303"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMOA2210639\/SUPPL_FILE\/NEJMOA2210639_DATA\u2010SHARING.PDF"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0902066"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2023.10.018"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-S010"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2020.02.086"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002453"},{"key":"e_1_2_7_21_1","unstructured":"National Institute for Health and Care Excellence.Hypertension in adults: diagnosis and management [Internet]. NICE Guideline 136.2019."},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy339"},{"issue":"9","key":"e_1_2_7_23_1","first-page":"588","article-title":"Pharmacologic treatment of hypertension: ACP and AAFP release recommendations for adults 60\u2009years and older","volume":"95","author":"Hauk L","year":"2017","journal-title":"Am Fam Physician"},{"key":"e_1_2_7_24_1","unstructured":"National Heart Foundation of Australia.Guideline for the diagnosis and management of hypertension in adults.2016."}],"container-title":["Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/nep.14414","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T23:45:29Z","timestamp":1738280729000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/nep.14414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,26]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1111\/nep.14414"],"URL":"https:\/\/doi.org\/10.1111\/nep.14414","archive":["Portico"],"relation":{},"ISSN":["1320-5358","1440-1797"],"issn-type":[{"value":"1320-5358","type":"print"},{"value":"1440-1797","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,26]]},"assertion":[{"value":"2024-09-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e14414"}}